MN SF1227

Establishes separate licensure categories for medical gas manufacturers, wholesalers, and dispensers under Minnesota Statutes chapter 151, each requiring board approval and applicable fees.

Reduces license fees for medical gas manufacturers and wholesalers from $5,260 to $260 per additional facility once the state receives $250,000,000 from opioid settlements or related fees, with effective date no earlier than July 1, 2024.

Creates exemptions for certain opiate manufacturers from registration fees, specifically excluding injectable opiate products distributed to hospitals and medication-assisted therapy opioids from fee calculations.

Clarifies the opiate epidemic response advisory council's role in determining grant awards and funding amounts based on appropriated funds, and specifies staggered initial membership terms ending September 30, 2022 and 2023.

Directs opioid settlement money into a separate state treasury account to fund the opiate epidemic response fund with $20,940,000 annually, with transfers from consulting firm settlements counted toward this minimum.